SEC Form 4 · accession 0001179110-16-029608
Editas Medicine, Inc. · EDIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles Albright
Officer — Chief Scientific Officer
Period of report
Sep 9, 2016
Accepted (ET)
Sep 13, 2016 · 5:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001650664
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $16.51 | Sep 9, 2016 | A | 225,000 | A | — | Sep 8, 2026 | Common Stock | 225,000 | 225,000 | D |
Explanation of responses
- F1This option was granted on September 9, 2016 and is scheduled to vest over four years with 25% of the shares scheduled to vest on August 22, 2017, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through August 22, 2020.